DexCom Inc. DXCM and Abbott Laboratories ABT are likely to launch their first over-the-counter (OTC) continuous glucose monitors (CGMs) in the coming months of 2024. Dexcom’s Stelo and Abbott’s Lingo ...
Medical Device Network on MSN
Abbott issues correction over incorrect FreeStyle Libre sensor readings
The correction relates to around three million sensors used in Abbott’s FreeStyle Libre 3 and Libre 3 Plus CGMs in the US.
DexCom, Inc.'s (NASDAQ: DXCM) continuous glucose monitors (CGM) are increasingly being used by diabetics to track their blood glucose levels, and based on the company's second-quarter results, the ...
Randomised controlled trial (RCT) assessed impact of two glucose monitoring systems on hypoglycaemia in people with type 1 diabetes EDINBURGH, Scotland, Jan. 30, 2018 /PRNewswire/ -- DexCom, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback